JP2017537156A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2017537156A5 JP2017537156A5 JP2017547368A JP2017547368A JP2017537156A5 JP 2017537156 A5 JP2017537156 A5 JP 2017537156A5 JP 2017547368 A JP2017547368 A JP 2017547368A JP 2017547368 A JP2017547368 A JP 2017547368A JP 2017537156 A5 JP2017537156 A5 JP 2017537156A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- composition according
- formulated
- subject
- per day
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000008194 pharmaceutical composition Substances 0.000 claims 24
- 239000007788 liquid Substances 0.000 claims 10
- 239000000843 powder Substances 0.000 claims 8
- 244000298697 Actinidia deliciosa Species 0.000 claims 6
- 235000009436 Actinidia deliciosa Nutrition 0.000 claims 6
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 claims 6
- 239000010931 gold Substances 0.000 claims 6
- 229910052737 gold Inorganic materials 0.000 claims 6
- 210000001035 gastrointestinal tract Anatomy 0.000 claims 4
- 239000002775 capsule Substances 0.000 claims 3
- 241000894006 Bacteria Species 0.000 claims 2
- 241000606123 Bacteroides thetaiotaomicron Species 0.000 claims 2
- 206010010774 Constipation Diseases 0.000 claims 2
- 208000022559 Inflammatory bowel disease Diseases 0.000 claims 2
- 230000009286 beneficial effect Effects 0.000 claims 2
- 238000011260 co-administration Methods 0.000 claims 2
- 235000013325 dietary fiber Nutrition 0.000 claims 2
- 230000029087 digestion Effects 0.000 claims 2
- 102000038379 digestive enzymes Human genes 0.000 claims 2
- 108091007734 digestive enzymes Proteins 0.000 claims 2
- 208000002551 irritable bowel syndrome Diseases 0.000 claims 2
- 235000015110 jellies Nutrition 0.000 claims 2
- 239000008274 jelly Substances 0.000 claims 2
- 238000012423 maintenance Methods 0.000 claims 2
- 239000000203 mixture Substances 0.000 claims 2
- 150000008442 polyphenolic compounds Chemical class 0.000 claims 2
- 235000013824 polyphenols Nutrition 0.000 claims 2
- 235000013406 prebiotics Nutrition 0.000 claims 2
- 239000006041 probiotic Substances 0.000 claims 2
- 235000018291 probiotics Nutrition 0.000 claims 2
- 239000003826 tablet Substances 0.000 claims 2
- 206010003645 Atopy Diseases 0.000 claims 1
- 241001032450 Bacteroides cellulosilyticus Species 0.000 claims 1
- 241001135228 Bacteroides ovatus Species 0.000 claims 1
- 241000186000 Bifidobacterium Species 0.000 claims 1
- 241000186560 Blautia coccoides Species 0.000 claims 1
- 206010009900 Colitis ulcerative Diseases 0.000 claims 1
- 208000011231 Crohn disease Diseases 0.000 claims 1
- 241000605980 Faecalibacterium prausnitzii Species 0.000 claims 1
- 206010017993 Gastrointestinal neoplasms Diseases 0.000 claims 1
- 206010020751 Hypersensitivity Diseases 0.000 claims 1
- 206010061218 Inflammation Diseases 0.000 claims 1
- 241001134638 Lachnospira Species 0.000 claims 1
- 241000186660 Lactobacillus Species 0.000 claims 1
- 241000605947 Roseburia Species 0.000 claims 1
- 241000398180 Roseburia intestinalis Species 0.000 claims 1
- 241000192031 Ruminococcus Species 0.000 claims 1
- 241000123753 Ruminococcus bromii Species 0.000 claims 1
- 241000192026 Ruminococcus flavefaciens Species 0.000 claims 1
- 201000006704 Ulcerative Colitis Diseases 0.000 claims 1
- 208000026935 allergic disease Diseases 0.000 claims 1
- 230000007815 allergy Effects 0.000 claims 1
- 206010012601 diabetes mellitus Diseases 0.000 claims 1
- 239000000499 gel Substances 0.000 claims 1
- 230000004054 inflammatory process Effects 0.000 claims 1
- 230000000968 intestinal effect Effects 0.000 claims 1
- 229940039696 lactobacillus Drugs 0.000 claims 1
- 244000005706 microflora Species 0.000 claims 1
- 230000002265 prevention Effects 0.000 claims 1
- 230000000529 probiotic effect Effects 0.000 claims 1
- 208000024891 symptom Diseases 0.000 claims 1
- 235000019722 synbiotics Nutrition 0.000 claims 1
Priority Applications (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2022017185A JP7471668B2 (ja) | 2014-11-28 | 2022-02-07 | ゴールドキウイフルーツ組成物ならびにその調製および使用方法 |
| JP2024060245A JP2024088715A (ja) | 2014-11-28 | 2024-04-03 | ゴールドキウイフルーツ組成物ならびにその調製および使用方法 |
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| NZ70245414 | 2014-11-28 | ||
| NZ702454 | 2014-11-28 | ||
| NZ706405 | 2015-03-27 | ||
| NZ70640515 | 2015-03-27 | ||
| PCT/NZ2015/050200 WO2016085356A1 (en) | 2014-11-28 | 2015-11-27 | Gold kiwifruit compositions and methods of preparation and use therefor |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022017185A Division JP7471668B2 (ja) | 2014-11-28 | 2022-02-07 | ゴールドキウイフルーツ組成物ならびにその調製および使用方法 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2017537156A JP2017537156A (ja) | 2017-12-14 |
| JP2017537156A5 true JP2017537156A5 (enExample) | 2019-01-10 |
| JP7330667B2 JP7330667B2 (ja) | 2023-08-22 |
Family
ID=56074755
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2017547368A Active JP7330667B2 (ja) | 2014-11-28 | 2015-11-27 | ゴールドキウイフルーツ組成物ならびにその調製および使用方法 |
| JP2022017185A Active JP7471668B2 (ja) | 2014-11-28 | 2022-02-07 | ゴールドキウイフルーツ組成物ならびにその調製および使用方法 |
| JP2024060245A Pending JP2024088715A (ja) | 2014-11-28 | 2024-04-03 | ゴールドキウイフルーツ組成物ならびにその調製および使用方法 |
Family Applications After (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022017185A Active JP7471668B2 (ja) | 2014-11-28 | 2022-02-07 | ゴールドキウイフルーツ組成物ならびにその調製および使用方法 |
| JP2024060245A Pending JP2024088715A (ja) | 2014-11-28 | 2024-04-03 | ゴールドキウイフルーツ組成物ならびにその調製および使用方法 |
Country Status (16)
| Country | Link |
|---|---|
| US (4) | US10512663B2 (enExample) |
| EP (2) | EP4548775A3 (enExample) |
| JP (3) | JP7330667B2 (enExample) |
| KR (2) | KR20230156436A (enExample) |
| CN (3) | CN106999523A (enExample) |
| BR (1) | BR112017011078B1 (enExample) |
| CA (2) | CA2967263A1 (enExample) |
| DK (1) | DK3223838T3 (enExample) |
| ES (1) | ES3023661T3 (enExample) |
| FI (1) | FI3223838T3 (enExample) |
| MY (1) | MY188290A (enExample) |
| NZ (1) | NZ732197A (enExample) |
| PL (1) | PL3223838T3 (enExample) |
| PT (1) | PT3223838T (enExample) |
| SI (1) | SI3223838T1 (enExample) |
| WO (1) | WO2016085356A1 (enExample) |
Families Citing this family (31)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US10512663B2 (en) * | 2014-11-28 | 2019-12-24 | Anagenix Ip Limited | Gold kiwifruit compositions and methods of preparation and use therefor |
| KR101833503B1 (ko) * | 2016-12-26 | 2018-03-05 | 주식회사 엠디헬스케어 | 만성폐쇄성폐질환자에서 세균 메타게놈 분석을 통한 폐암 진단방법 |
| KR101833348B1 (ko) * | 2016-12-26 | 2018-03-02 | 주식회사 엠디헬스케어 | 세균 메타게놈 분석을 통한 유방암 진단방법 |
| KR101940426B1 (ko) * | 2016-12-28 | 2019-01-18 | 주식회사 엠디헬스케어 | 세균 메타게놈 분석을 통한 대장종양 진단 방법 |
| KR101942197B1 (ko) * | 2016-12-28 | 2019-01-24 | 주식회사 엠디헬스케어 | 세균 메타게놈 분석을 통한 전립선질환 진단 방법 |
| US11413318B2 (en) * | 2017-06-06 | 2022-08-16 | Sami-Sabinsa Group Limited | Compositions and methods for management of atrophic gastritis and colitis |
| WO2019075273A1 (en) * | 2017-10-11 | 2019-04-18 | Gu Jennifer L | INTESTINAL HEALTH COMPOSITIONS |
| KR102130485B1 (ko) * | 2017-10-13 | 2020-07-06 | 주식회사 엠디헬스케어 | 세균 메타게놈 분석을 통한 알츠하이머치매 진단방법 |
| KR102007786B1 (ko) * | 2017-10-18 | 2019-08-07 | 주식회사 엠디헬스케어 | 세균 메타게놈 분석을 통한 두경부암 진단방법 |
| CA3088630A1 (en) | 2017-12-15 | 2019-06-20 | Solarea Bio, Inc. | Microbial compositions and methods for treating type 2 diabetes, obesity, and metabolic syndrome |
| KR101940950B1 (ko) | 2018-01-23 | 2019-01-21 | 주식회사 엠디헬스케어 | 세균 메타게놈 분석을 통한 담관암 진단방법 |
| KR101944662B1 (ko) * | 2018-02-14 | 2019-02-01 | 주식회사 엠디헬스케어 | 세균 메타게놈 분석을 통한 뇌졸중 진단방법 |
| US11980647B2 (en) | 2018-09-05 | 2024-05-14 | Solarea Bio, Inc. | Methods and compositions for treating musculoskeletal diseases, treating inflammation, and managing symptoms of menopause |
| EP3846830A4 (en) | 2018-09-05 | 2022-07-06 | Solarea Bio, Inc. | METHODS AND COMPOSITIONS FOR THE TREATMENT OF MUSCULOSKELETAL DISEASES |
| CN109288104B (zh) * | 2018-11-12 | 2023-09-01 | 方家铺子（莆田）绿色食品有限公司 | 一种桂圆鲜果挂黄处理设备及其处理方法 |
| US11622974B2 (en) | 2019-01-18 | 2023-04-11 | C.P. Kelco U.S., Inc. | Prebiotic composition and its use |
| CN110279814A (zh) * | 2019-06-10 | 2019-09-27 | 湖北虹玮农业有限公司 | 一种用于中老年慢性便秘的功能食品 |
| US11684645B2 (en) * | 2019-11-26 | 2023-06-27 | Tci Co., Ltd. | Actinidia chinensis Planch ferment and use thereof |
| WO2022115709A2 (en) * | 2020-11-30 | 2022-06-02 | January, Inc. | Methods and composition for treating metabolic syndrome |
| US20220233151A1 (en) * | 2021-01-22 | 2022-07-28 | Ethicon Llc | Bariatric surgery post-surgical monitoring |
| KR102543549B1 (ko) * | 2021-01-26 | 2023-06-15 | 주식회사 다솔마임마케팅사업부 | 칼라만시 발포정 및 그 제조 방법 |
| CN113521109A (zh) * | 2021-06-28 | 2021-10-22 | 广州知易生物科技有限公司 | 解纤维素拟杆菌在预防和/或治疗炎症性肠病中的应用 |
| CN116076711A (zh) * | 2021-11-05 | 2023-05-09 | 百岳特生物技术（上海）有限公司 | 益生质组合物及其用途 |
| US12343366B2 (en) * | 2021-11-05 | 2025-07-01 | Tci Co., Ltd. | Prebiotic composition and method for improving intestinal health using the same |
| WO2023092150A1 (en) | 2021-11-22 | 2023-05-25 | Solarea Bio, Inc. | Methods and compositions for treating musculoskeletal diseases, treating inflammation, and managing symptoms of menopause |
| US20230190834A1 (en) | 2021-12-21 | 2023-06-22 | Solarea Bio, Inc. | Immunomodulatory compositions comprising microbial entities |
| JP7701899B2 (ja) * | 2022-09-14 | 2025-07-02 | 花王株式会社 | クロロゲン酸類吸収量の予測方法 |
| KR102536627B1 (ko) * | 2022-09-30 | 2023-05-30 | (주)바이텍 | 키위 발효물을 포함하는 알코올성 간손상 예방 또는 개선용 조성물 |
| US20250195588A1 (en) * | 2023-12-18 | 2025-06-19 | First Day Life, Inc. | Ingestible Nutritive Compositions With Prebiotics, Probiotics, and Postbiotics |
| US20250195594A1 (en) * | 2023-12-18 | 2025-06-19 | First Day Life Inc. | Ingestible Nutritive Compositions With Prebiotics, Probiotics, and Postbiotics |
| NL2038369B1 (en) * | 2024-07-31 | 2025-03-06 | Sunbird Company Ltd | A composition of natural kiwifruit powder and postbiotics and its use in constipation improvement |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US22355A (en) | 1858-12-21 | sherwood | ||
| JP2750767B2 (ja) * | 1990-02-21 | 1998-05-13 | 雪印乳業株式会社 | 新規糖アルコール |
| NZ235972A (en) | 1990-11-06 | 1995-04-27 | Amaranathan Balasingham | Fruit product by soft pulping after skin removal |
| CN1107308A (zh) * | 1994-02-25 | 1995-08-30 | 中国癌症研究基金会 | 猕猴桃天然营养口服液 |
| JPH10313822A (ja) * | 1997-05-20 | 1998-12-02 | Pola Chem Ind Inc | 腸内細菌叢改善剤及びそれを含有する組成物 |
| AT503521A1 (de) * | 2006-05-05 | 2007-11-15 | Omnica Gmbh | Verwendung eines extraktes von kiwi-frucht |
| NZ554991A (en) * | 2007-05-03 | 2009-11-27 | Vital Food Processors Ltd | Powdered kiwifruit extract compositions for the treatment of digestive dysfunction and/or gastrointestinal tract disorders |
| USPP22355P3 (en) * | 2009-06-30 | 2011-12-20 | Zespri Group Limited | Kiwifruit plant named ‘ZESY002’ |
| MY162344A (en) * | 2010-01-28 | 2017-06-15 | Ab-Biotics S A | Probiotic composition for use in the treatment of bowel inflammation |
| US10512663B2 (en) * | 2014-11-28 | 2019-12-24 | Anagenix Ip Limited | Gold kiwifruit compositions and methods of preparation and use therefor |
-
2015
- 2015-11-27 US US15/529,734 patent/US10512663B2/en active Active
- 2015-11-27 EP EP25151514.4A patent/EP4548775A3/en active Pending
- 2015-11-27 ES ES15863825T patent/ES3023661T3/es active Active
- 2015-11-27 CA CA2967263A patent/CA2967263A1/en active Pending
- 2015-11-27 DK DK15863825.4T patent/DK3223838T3/da active
- 2015-11-27 CA CA3200468A patent/CA3200468A1/en active Pending
- 2015-11-27 FI FIEP15863825.4T patent/FI3223838T3/fi active
- 2015-11-27 WO PCT/NZ2015/050200 patent/WO2016085356A1/en not_active Ceased
- 2015-11-27 PL PL15863825.4T patent/PL3223838T3/pl unknown
- 2015-11-27 CN CN201580064171.3A patent/CN106999523A/zh active Pending
- 2015-11-27 SI SI201532064T patent/SI3223838T1/sl unknown
- 2015-11-27 EP EP15863825.4A patent/EP3223838B1/en active Active
- 2015-11-27 MY MYPI2017701750A patent/MY188290A/en unknown
- 2015-11-27 KR KR1020237037806A patent/KR20230156436A/ko active Pending
- 2015-11-27 JP JP2017547368A patent/JP7330667B2/ja active Active
- 2015-11-27 BR BR112017011078-4A patent/BR112017011078B1/pt active IP Right Grant
- 2015-11-27 CN CN202310572047.4A patent/CN116763830A/zh active Pending
- 2015-11-27 PT PT158638254T patent/PT3223838T/pt unknown
- 2015-11-27 CN CN202310308827.8A patent/CN116270773A/zh active Pending
- 2015-11-27 NZ NZ732197A patent/NZ732197A/en unknown
- 2015-11-27 KR KR1020177017760A patent/KR102599549B1/ko active Active
-
2019
- 2019-11-06 US US16/675,936 patent/US11090348B2/en active Active
-
2021
- 2021-06-11 US US17/345,478 patent/US11642386B2/en active Active
-
2022
- 2022-02-07 JP JP2022017185A patent/JP7471668B2/ja active Active
-
2023
- 2023-03-22 US US18/188,045 patent/US20240091291A1/en active Pending
-
2024
- 2024-04-03 JP JP2024060245A patent/JP2024088715A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2017537156A5 (enExample) | ||
| US11642386B2 (en) | Gold kiwifruit compositions and methods of preparation and use therefor | |
| ES2761333T3 (es) | Composiciones farmacéuticas que contienen Pediococcus y métodos para reducir los síntomas de síndromes gastroenterológicos | |
| Montemurno et al. | What would you like to eat, Mr CKD Microbiota? A Mediterranean Diet, please! | |
| Vandenplas et al. | Randomised clinical trial: the synbiotic food supplement Probiotical vs. placebo for acute gastroenteritis in children | |
| RU2015137415A (ru) | Применение штамма htf-f фекальной бактерии prausnitzii htf-f (dsm 26943) для подавления воспаления | |
| JP2012520325A5 (enExample) | ||
| BRPI0517273B1 (pt) | composição contendo uma mistura de três bactérias probióticas, uso desta para a prevenção e/ou tratamento de infecções do trato respiratório superior e na regularização da funcionalidade intestinal do organismo acometido por essas patologias e kit contendo uma mistura de três bactérias probióticas | |
| JP2018526370A5 (enExample) | ||
| JP2019508486A5 (enExample) | ||
| RU2017120146A (ru) | Штаммы Lactobacillus или Bifidobacterium для поддержания гомеостаза | |
| JP2016537410A5 (enExample) | ||
| CN115066187A (zh) | 多菌株益生菌组合物及其用途 | |
| WO2014184644A1 (en) | Composition comprising lactic acid bacteria and/or bifidobacteria for use in the preventive and/or curative treatment of bacterial infections and/or inflammations of the urinary tract and/or prostate which are the cause of prostatitis and prostatic hypertrophy | |
| US9889166B2 (en) | Treating low production of mucus in the gastrointestinal tract with S. thermophilus | |
| ES2400187T3 (es) | Bacterias lácticas y su uso en la prevención de la diarrea | |
| Guarner et al. | World Gastroenterology Organisation practice guideline: probiotics and prebiotics-May 2008: guideline | |
| JP2018531598A5 (enExample) | ||
| Nandal et al. | NAVIGATING INFLAMMATORY BOWEL DISEASE (IBD): INSIGHTS INTO MICROBIAL DYNAMICS, DIETARY INTERVENTIONS AND PROBIOTIC STRATEGIES FOR GUT HEALTH. | |
| Patel et al. | The role of gut microbiome supplementation in COVID-19 management | |
| NZ769769B2 (en) | Gold kiwifruit compositions and methods of preparation and use therefor | |
| Kuate et al. | In Vitro Comparative Study of the Survival of Probiotic Capsules in a Simulated Gastric Environment | |
| Florina et al. | Exploring the interconnection between diet, microbiome, and human health: a systematic review | |
| Stevenson et al. | Probiotics, with special emphasis on their role in the management of irritable bowel syndrome | |
| Calafiore et al. | Gastroenterology and Hepatology Research |